Belvedere Trading »

Immunovant shares owned by Belvedere Trading

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2023-09-30 $2.2M 57k 38.39
2021-09-30 $127k 15k 8.54

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Meta Platforms Cl A (META)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon Call Option (AMZN)
Spdr Gold Tr Gold Shs (GLD)
Microstrategy Cl A New (MSTR)
Ishares Silver Tr Ishares (SLV)
Kraneshares Tr Global Carb Stra (KRBN)
Global X Fds Global X Uranium Call Option (URA)
Alphabet Cap Stk Cl A (GOOGL)
Carvana Cl A Call Option (CVNA)

View all positions for Belvedere Trading

Top funds holding Immunovant

Vanguard Group
Point72 Asset Management
Perceptive Advisors
T. Rowe Price Associates
Alpine Partners VI
Logos Global Management
Cormorant Asset Management
Citadel Advisors
Commodore Capital
Boxer Capital
Redmile Group
Fred Alger Management
Millennium Management
Dimensional Fund Advisors
Ikarian Capital

View all funds holding Immunovant